<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutr J</journal-id><journal-id journal-id-type="iso-abbrev">Nutr J</journal-id><journal-title-group><journal-title>Nutrition Journal</journal-title></journal-title-group><issn pub-type="epub">1475-2891</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26022214</article-id><article-id pub-id-type="pmc">4477321</article-id><article-id pub-id-type="publisher-id">43</article-id><article-id pub-id-type="doi">10.1186/s12937-015-0043-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Improvement of antioxidant status after Brazil nut intake in hypertensive and dyslipidemic subjects</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Huguenin</surname><given-names>Grazielle V. B.</given-names></name><address><email>grazielle.huguenin@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Oliveira</surname><given-names>Glaucia M. M.</given-names></name><address><email>glauciamoraesoliveira@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Moreira</surname><given-names>Annie S. B.</given-names></name><address><email>anniebello@gmail.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Saint&#x02019;Pierre</surname><given-names>Tatiana D.</given-names></name><address><email>tatispierre@puc-rio.br</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Gon&#x000e7;alves</surname><given-names>Rodrigo A.</given-names></name><address><email>rodrigoagoncalves@gmail.com</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Pinheiro-Mulder</surname><given-names>Alessandra R.</given-names></name><address><email>alessandra.mulder@gmail.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Teodoro</surname><given-names>Anderson J.</given-names></name><address><email>atteodoro@gmail.com</email></address><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Luiz</surname><given-names>Ronir R.</given-names></name><address><email>ronir@iesc.ufrj.br</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Rosa</surname><given-names>Glorimar</given-names></name><address><email>glorimar@nutricao.ufrj.br</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label>Institute of Heart Edson Saad, Federal Universityof Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil </aff><aff id="Aff2"><label>2</label>Clinic of Atherosclerosis and Cardiovascular Disease Prevention, National Institute of Cardiology (INC), Rio de Janeiro, Brazil </aff><aff id="Aff3"><label>3</label>Chemistry Department, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de Janeiro, Brazil </aff><aff id="Aff4"><label>4</label>Nutritional Biochemistry Laboratory, Federal University of Rio de Janeiro State (UNIRIO), Rio de Janeiro, Brazil </aff><aff id="Aff5"><label>5</label>Departamento de Nutri&#x000e7;&#x000e3;o e Diet&#x000e9;tica, Instituto de Nutri&#x000e7;&#x000e3;o Josu&#x000e9; de Castro &#x02013; Cidade Universit&#x000e1;ria &#x02013; Ilha do Fund&#x000e3;o, Av. Carlos Chagas Filho, 373, Pr&#x000e9;dio do Centro de Ci&#x000ea;ncias da Sa&#x000fa;de, Bloco J, 2&#x000b0; andar, sala 25, CEP: 21941-902 Rio de Janeiro, Brazil </aff></contrib-group><pub-date pub-type="epub"><day>29</day><month>5</month><year>2015</year></pub-date><pub-date pub-type="pmc-release"><day>29</day><month>5</month><year>2015</year></pub-date><pub-date pub-type="collection"><year>2015</year></pub-date><volume>14</volume><elocation-id>54</elocation-id><history><date date-type="received"><day>20</day><month>11</month><year>2014</year></date><date date-type="rev-recd"><day>20</day><month>11</month><year>2014</year></date><date date-type="accepted"><day>18</day><month>5</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9; Huguenin et al. 2015</copyright-statement><license license-type="open-access"><license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Objectives</title><p>To investigate the effect of partially defatted Granulated Brazil nut (GBN) on biomarkers of oxidative stress and antioxidant status of hypertensive and dyslipidemic patients on nutrition and drug approaches.</p></sec><sec><title>Methods</title><p>Ninety one hypertensive and dyslipidemic subjects of both genders (51.6&#x000a0;% men), mean age 62.1&#x02009;&#x000b1;&#x02009;9.3&#x000a0;years, performed a randomized crossover trial, double-blind, placebo controlled. Subjects received a diet and partially defatted GBN 13&#x000a0;g per day (&#x02248;227.5&#x000a0;&#x003bc;g/day of selenium) or placebo for twelve weeks with four-week washout interval. Anthropometric, laboratory and clinic characteristics were investigated at baseline. Plasma selenium (Se), plasma glutathione peroxidase (GPx3) activity, total antioxidant capacity (TAC), 8-epi PGF<sub>2&#x003b1;</sub> and oxidized LDL were evaluated at the beginning and in the end of each intervention.</p></sec><sec><title>Results</title><p>GBN intake significantly increased plasma Se from 87.0&#x02009;&#x000b1;&#x02009;16.8 to 180.6&#x02009;&#x000b1;&#x02009;67.1&#x000a0;&#x003bc;g/L, increased GPx3 activity in 24,8&#x000a0;% (from 112.66&#x02009;&#x000b1;&#x02009;40.09 to 128.32&#x02009;&#x000b1;&#x02009;38.31&#x000a0;nmol/min/mL, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0,05), and reduced 3.25&#x000a0;% of oxidized-LDL levels (from 66.31&#x02009;&#x000b1;&#x02009;23.59 to 60.68&#x02009;&#x000b1;&#x02009;20.88 U/L, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). An inverse association between GPx3 and oxidized LDL levels was observed after supplementation with GBN by simple model (&#x003b2; -0.232, <italic>p</italic>&#x02009;=&#x02009;0.032) and after adjustment for gender, age, diabetes and BMI (&#x003b2; -0.298, <italic>p</italic>&#x02009;=&#x02009;0.008). There wasn&#x02019;t association between GPx3 and 8-epi PGF<sub>2&#x003b1;</sub> (&#x003b2; -0.209, <italic>p</italic>&#x02009;=&#x02009;0.052) by simple model.</p></sec><sec><title>Conclusion</title><p>The partially defatted GBN intake has a potential benefit to increase plasma selenium, increase enzymatic antioxidant activity of GPx3 and to reduction oxidation in LDL in hypertensive and dyslipidemic patients.</p></sec><sec><title>Trial registration</title><p>ClinicalTrials.gov Identifier <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT01990391">NCT01990391</ext-link>; November 20, 2013.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Brazil nut</kwd><kwd>Selenium</kwd><kwd>Serum lipids</kwd><kwd>Dyslipidemia</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2015</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p>Brazil nut is the food retaining the largest amount of selenium (Se) in its composition [<xref ref-type="bibr" rid="CR1">1</xref>]. Se is a key component incorporated to selenoproteins involved in enzymatic functions of antioxidant, anti-inflammatory and thyroid hormones metabolism [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. It was demonstrated that the Brazil nut intake is able to significantly improve glutathione peroxidase (GPx) activity on individuals with low plasma Se [<xref ref-type="bibr" rid="CR4">4</xref>]. GPx is a selenoprotein involved in the dismutation of hydroperoxides.</p><p>Reactive oxygen species (ROS) production is part of the human metabolism and is found in many physiological conditions [<xref ref-type="bibr" rid="CR5">5</xref>]. Although, when there is an overproduction of ROS the body has an efficient antioxidant system available, which manages to control and reestablish balance. Therefore, the oxidative stress results from the imbalance of pro and antioxidants, with predominance of oxidants and consequent oxidative damage [<xref ref-type="bibr" rid="CR6">6</xref>]. There is an association between atherosclerosis risk factors and ROS vascular production increase, since the main risk factors are genetics, age, hypertension, dyslipidemia, diabetes and tobacco use [<xref ref-type="bibr" rid="CR7">7</xref>].</p><p>Lipoxygenases are production sources of ROS, since they catalyze the oxygen incorporation in polyunsaturated fatty acids [<xref ref-type="bibr" rid="CR8">8</xref>]. Some lipoxygenase isoforms are related to the promotion of atherosclerosis by ROS generation and lipid oxidation, such as oxidized-LDL [<xref ref-type="bibr" rid="CR9">9</xref>]. In healthy individuals, the amount of circulating oxidized-LDL, independently, is a predictor to atherosclerosis [<xref ref-type="bibr" rid="CR10">10</xref>] and clinical coronary artery disease [<xref ref-type="bibr" rid="CR11">11</xref>]; based in these situations, oxidized-LDL plasma concentration evaluation has been suggested as a risk biomarker for CVD, besides LDL-c concentrations. F2-isoprostanes are oxidized products of arachidonic acid generated from non-enzymatic reactions; they can derive from esterified fatty acids such as phospholipid membrane or circulating LDL [<xref ref-type="bibr" rid="CR12">12</xref>]. Once formed, these compounds are structurally stable <italic>in vivo</italic>, circulating in its free form or remaining esterified in phospholipids; there can be found in both urine and plasma, hence considered good oxidative stress biomarkers [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p>Hypertension is one of the risk factors for acute myocardial infarction (MI), heart failure, stroke, peripheral arterial disease, aortic aneurysm and is one of the causes of chronic kidney disease [<xref ref-type="bibr" rid="CR14">14</xref>]. Hypertension is associated to increase in oxidative stress and reduction of two antioxidant enzymes activity [<xref ref-type="bibr" rid="CR15">15</xref>]. High levels of serum LDL-c and triglycerides, and low levels of HDL-c are also risk factors for cardiovascular disease [<xref ref-type="bibr" rid="CR16">16</xref>] and a study presents that different types of hyperlipidemia are associated to oxidative stress [<xref ref-type="bibr" rid="CR17">17</xref>].</p><p>Our hypothesis is based on the benefit effect related to the bioactive compounds of the Brazil nut on the management of hypertension and dyslipidemia, in order to improve antioxidant status in such individuals. The aim of this study was to investigate the effect of partially defatted Granulated Brazil nut on biomarkers of oxidative stress and antioxidant status of hypertensive and dyslipidemic patients on nutrition and drug approaches.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Population</title><p>One hundred and thirty-seven subjects were screened at the Clinic of Atherosclerosis and Cardiovascular Disease Prevention of the National Institute of Cardiology, Rio de Janeiro, RJ, Brazil, from September 2011 to September 2012. All the patients have been followed by a multidisciplinary team at the moment of the recruitment for the present study. Of the 137 subjects screened, 125 patients were eligible for the study. Males and females aged&#x02009;&#x0003e;&#x02009;20&#x000a0;years with a referred diagnosis of dyslipidemia and hypertension that were taking medication for both conditions were included in the study. The exclusion criteria was food allergy to the Brazil nut; pregnancy or breastfeeding; undergoing in a low calorie diet; using dietary supplements containing antioxidant vitamins or minerals; using corticoid substances; and thyroid diseases, chronic renal failure, liver disease, cancer, rheumatic disease or systemic connective tissue disease. The Ethics Committee in Research of the National Institute of Cardiology, protocol 0316/11, approved the study, and it was registered at ClinicalTrials.gov (NCT01990391).</p></sec><sec id="Sec4"><title>Study design and dietary intervention</title><p>A randomized, placebo-controlled, double-blind crossover trial was performed. Subjects were provided either partially defatted Granulated Brazil nut or placebo along with nutritional counselling for dyslipidemia and hypertension [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Each supplementation period lasted three months (twelve weeks) with monthly returns. After the first step of intervention, subjects underwent a washout period of four-week, based on SELGEN study [<xref ref-type="bibr" rid="CR20">20</xref>], when did not receive any supplements. Randomization was simple, in blocks of 10 and based on a table of random numbers that were blinded from all researchers except one who encoded the bottles of supplements and had no contact with the center where the study was conducted.</p><p>Subjects were advised to use 01 standard measure containing 13&#x000a0;g per day (on average containing 227.5&#x000a0;&#x003bc;g of selenium) of partially defatted Granulated Brazil nut (Ouro Verde Amaz&#x000f4;nia&#x000ae; - Mato Grosso, Brazil). Partially defatted granulated Brazil nut was used in this study instead of Brazil nut kernel because the Granulated Brazil nut has high Se content compared to the Brazil nut (227,5&#x000a0;&#x003bc;g vs. 249,21&#x000a0;&#x003bc;g [<xref ref-type="bibr" rid="CR21">21</xref>], respectively) and similar centesimal composition between each other, except for the total fat decrease and less calorie. In addition, Granulated Brazil nut allowed to blind the study and is already commercialized. The placebo (Mane do Brazil Ind&#x000fa;stria e Com&#x000e9;rcio Ltda, Rio de Janeiro, Brazil) was composed of flavored cassava flour (which has a nutty aroma) and was lightly stained (with natural caramel pigment) to approximate the appearance and smell of Granulated Brazil nut. Subjects were advised to consume 01 standard measure containing 10&#x000a0;g daily of placebo. The calculation of the diet was individualized and based on Total Energy Expenditure (TEE) formulas for men and women according to their nutritional status, age, and used the physical activity coefficient of 1.0 which is related to physical inactivity [<xref ref-type="bibr" rid="CR22">22</xref>]. The distribution of macronutrients was balanced, and nutritional counselling followed the guidelines for hypertension and dyslipidemia [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].</p></sec><sec id="Sec5"><title>Composition of the supplements</title><p>Partially defatted Granulated Brazil nut (Ouro Verde Amaz&#x000f4;nia&#x000ae; - Mato Grosso, Brazil) is made by the mechanical cold extraction of the extra-virgin oil of Brazil nut at atmosphere temperature. Thirteen grams of the partially defatted Granulated Brazil nut contained 64.4&#x000a0;kcal, 2.8&#x000a0;g carbohydrate, 3.4&#x000a0;g protein, 5.6&#x000a0;g total fat and 2.6&#x000a0;g dietary fiber. Ten grams of the placebo (flavored cassava flour) had a nutritional composition of [<xref ref-type="bibr" rid="CR21">21</xref>]: 36.5&#x000a0;kcal, 8.92&#x000a0;g carbohydrate, 0.12&#x000a0;g protein, 0.03&#x000a0;g total fat, 0.65&#x000a0;g dietary fiber and 0.07&#x000a0;&#x003bc;g selenium.</p></sec><sec id="Sec6"><title>Analysis of selenium in partially defatted Granulated Brazil nut</title><p>The selenium content was analyzed according to the method described by Benicasa <italic>et al.</italic> [<xref ref-type="bibr" rid="CR23">23</xref>] and adapted to use 0.3&#x000a0;g of sample, 6&#x000a0;mL of bidistilled nitric acid and 3&#x000a0;mL of hydrogen peroxide (both from Merck&#x000ae;, Germany). Samples were decomposed in a microwave oven (Provecto Analitica DGT 100 plus). The resulting solutions were transferred to polyethylene flasks and diluted to 50&#x000a0;mL with distilled and deionized water (MilliQ System, Millipore, USA, minimum resistivity of 18 M&#x003a9; cm). The reading of the <sup>77</sup>Se isotope was performed by ICP-MS (Agilent 7500 CX series). The accuracy was evaluated by recovery tests and analysis of a dogfish liver certified reference material for trace metals (DOLT-3, National Research Council Canada standard, Canada). Recoveries of approximately 100&#x000a0;% were observed. The amount of Se observed in Granulated Brazil nut was 17.5&#x02009;&#x000b1;&#x02009;0.2&#x000a0;&#x003bc;g/g, corresponding to 227.5&#x000a0;&#x003bc;g in 13&#x000a0;g of BNG.</p></sec><sec id="Sec7"><title>Evaluation questionnaires</title><p>A questionnaire was used to obtain information about sociodemographics characteristics, medical history, lifestyle, and the use of current medication. To assess physical activity, a previously validated questionnaire was used [<xref ref-type="bibr" rid="CR24">24</xref>]. Patients who performed at least 150&#x000a0;min of moderate intensity exercise per week, according to international recommendations, were considered physically active [<xref ref-type="bibr" rid="CR25">25</xref>].</p></sec><sec id="Sec8"><title>Anthropometric, blood pressure and laboratory measurements</title><p>Anthropometric evaluation was performed at baseline and included measurements of weight (kg), height (m), waist circumference (cm) and calculation of BMI (kg/m<sup>2</sup>). BMI was classified according to WHO [<xref ref-type="bibr" rid="CR26">26</xref>].</p><p>Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were evaluated using a sphygmomanometer. The SBP and DBP were measured twice by a trained professional, with a 1&#x000a0;min interval between the two measurements and the average value was used as the patient&#x02019;s blood pressure.</p><p>Blood samples were collected after 12&#x000a0;h of overnight fasting, and laboratory evaluations were performed by an automated method (ARCHITECT <italic>ci</italic>8200, Abbott ARCHIECT&#x000ae;, Abbott Park, IL, USA) using commercial kits (Abbott ARCHITECT <italic>c</italic>8000&#x000ae;, Abbott Park, IL, USA). Serum triglyceride levels, total cholesterol and HDL-cholesterol (HDL-c) were evaluated. The LDL-cholesterol (LDL-c) were calculated using the Friedewald <italic>et al.</italic> formula [<xref ref-type="bibr" rid="CR27">27</xref>].</p><p>Plasma Se levels were determined in plasma samples collected in NH Trace Element tubes with sodium heparin (VACUETTE&#x000ae;) and stored at&#x02009;&#x02212;&#x02009;20&#x000a0;&#x000b0;C until the time of analysis. The analysis were carried out in an inductively coupled plasma mass spectrometer (NexIon&#x02122; 300X, PerkinElmer, Massachusetts, USA), following the method adapted from [<xref ref-type="bibr" rid="CR28">28</xref>]. Plasma samples (0.5&#x000a0;g) were added with 0.5&#x000a0;mL nitric acid and diluted with water to 5.0&#x000a0;mL final volume. In this case, most abundant <sup>80</sup>Se isotope was monitored, due to the low Se concentrations found in plasma samples and the analysis was carried out in DRC mode with 0.75&#x000a0;mL&#x000a0;min<sup>&#x02212;1</sup> of methane to circumvent the interferences. The plasma Se levels were used as a marker of adherence to the consumption of the supplement. Plasma Se was considered to be low when plasma levels were &#x0003c;90&#x000a0;&#x003bc;g/L [<xref ref-type="bibr" rid="CR29">29</xref>].</p><p>The antioxidant activity of plasma glutathione peroxidase (GPx3) was determined by colorimetric assay (Cayman Inc., US) based on Paglia&#x00026; Valentine method [<xref ref-type="bibr" rid="CR30">30</xref>] with sensibility of 50&#x000a0;nmol/min/mL, intra-assay variation coefficient 5.7&#x000a0;% and inter-assay variation coefficient 7.2&#x000a0;%.</p><p>Plasma total antioxidant capacity (TAC) was evaluated by radical 2,2-diphenyl-1-picrylhydrazyl scan (DPPH) [<xref ref-type="bibr" rid="CR31">31</xref>].</p><p>As oxidative stress markers 8-isoprostane (8-epi PGF2&#x003b1;) and oxidized LDL were assessed in plasma. Concentrations of 8-epiPGF2a in the plasma samples were determined by ELISA method [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>] with commercial kit (Cayman Chemicals, Ann Arbor, Michigan, USA) with sensibility of 2.7&#x000a0;pg/mL.</p><p>Oxidized LDL was determined by ELISA method [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>] with commercial kit (Mercodia, Uppsala, Sweden). Samples were diluted in 1:6400. The intra-assay variation coefficient was 6.13&#x000a0;% and the sensibility was 0.05&#x000a0;ng/mL.</p></sec><sec id="Sec9"><title>Statistical methods</title><p>The sample size calculation was performed with a pilot sample made up of the first 10 participants, considering an increase of 15&#x000a0;nmol/min/mL (15&#x000a0;%) on GPx3 activity after Brazil nut intervention. A power of 80&#x000a0;% and a bilateral confidence interval of 90&#x000a0;% were considered. The calculated sample size was 63 per group and this number was increased by 30&#x000a0;% (to total 81 subjects) to account for possible losses. The results were presented as the mean&#x02009;&#x000b1;&#x02009;SD or median (25<sup>th</sup>&#x02013;75<sup>th</sup> percentile). The normality of the variables was investigated using the Kolmogorov-Smirnov test. To assess the intra intervention group&#x02019;s (Granulated Brazil nut and placebo) effect the paired Student&#x02019;s <italic>t</italic>-test was used, while the effect between groups was assessed by the Student&#x02019;s <italic>t</italic>-test or Mann&#x02013;Whitney test according to the distribution of variables. A significance level of p&#x02009;&#x0003c;&#x02009;0.05 was considered significant. Simple and multiple linear regression models were used to analyze relationships between GPx3 activity and oxidized LDL and 8-epi PGF2&#x003b1;. Multiple linear regression model was adjusted for gender, age, diabetes and BMI. Statistical analyses were conducted with IBM&#x000ae; SPSS&#x000ae; Statistics software version 21 and the significance value considered was p&#x02009;&#x0003c;&#x02009;0.05.</p></sec></sec><sec id="Sec10"><title>Results</title><p>One hundred and twenty five patients were randomized and 91 concluded all stages of the study, resulting in a 27.2&#x000a0;% loss of follow up. Figure&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref> shows the flow chart and losses throughout the study. The drop out in the follow-up was higher during supplementation with partially defatted Granulated Brazil nut, but there was no report of withdrawal due to the taste of the supplement. Individuals who completed the study protocol were older, with less schooling and lower serum glucose (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>), in relation to other parameters, there was no difference between patients who did not complete and those who completed the study.<fig id="Fig1"><label>Fig. 1</label><caption><p>Flow chart of patients in each study phase</p></caption><graphic xlink:href="12937_2015_43_Fig1_HTML" id="d30e700"/></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>Characteristics of the group that completed the study compared to those who did not complete the study</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th>Completed</th><th>Did not complete</th><th rowspan="2">p</th></tr><tr><th>(<italic>n</italic>&#x02009;=&#x02009;91)</th><th>(<italic>n</italic>&#x02009;=&#x02009;34)</th></tr></thead><tbody><tr><td>Age (years)</td><td>62.1&#x02009;&#x000b1;&#x02009;9.3</td><td>56.9&#x02009;&#x000b1;&#x02009;10.5</td><td>0.008</td></tr><tr><td>Male &#x02013; n (%)</td><td>47 (51.6)</td><td>19 (55.9)</td><td>NS</td></tr><tr><td>Diabetics &#x02013; n (%)</td><td>42 (46.2)</td><td>17 (50.0)</td><td>NS</td></tr><tr><td>Stroke &#x02013; n (%)</td><td>06 (6.6)</td><td>02 (5.9)</td><td>NS</td></tr><tr><td>AMI &#x02013; n (%)</td><td>39 (42.9)</td><td>11 (32.4)</td><td>NS</td></tr><tr><td>Percutaneous coronary</td><td rowspan="2">22 (24.2)</td><td rowspan="2">08 (23.5)</td><td rowspan="2">NS</td></tr><tr><td>Angioplasty &#x02013; n (%)</td></tr><tr><td>CABG &#x02013; n (%)</td><td>29 (31.9)</td><td>08 (23.5)</td><td>NS</td></tr><tr><td>Angina &#x02013; n (%)</td><td>36 (39.6)</td><td>16 (47.1)</td><td>NS</td></tr><tr><td>Time of diabetes (years)</td><td>10.6&#x02009;&#x000b1;&#x02009;11.2</td><td>4.9&#x02009;&#x000b1;&#x02009;7.9</td><td>NS</td></tr><tr><td>Time of hypertension (years)</td><td>11.8&#x02009;&#x000b1;&#x02009;9.7</td><td>10.7&#x02009;&#x000b1;&#x02009;8.6</td><td>NS</td></tr><tr><td>Time of dyslipidemia (years)</td><td>10.1&#x02009;&#x000b1;&#x02009;9.7</td><td>9.3&#x02009;&#x000b1;&#x02009;7.8</td><td>NS</td></tr><tr><td>Smokers &#x02013; n (%)</td><td>02 (2.2)</td><td>02 (6.3)</td><td>NS</td></tr><tr><td>Alcohol use &#x02013; n (%)</td><td>32 (37.2)</td><td>09 (29.0)</td><td>NS</td></tr><tr><td>Sedentary &#x02013; n (%)</td><td>68 (74.7)</td><td>27 (79.4)</td><td>NS</td></tr><tr><td>Marital status (married) &#x02013; n (%)</td><td>54 (60.0)</td><td>20 (62.5)</td><td>NS</td></tr><tr><td>Schooling &#x02013; n (%)</td><td/><td/><td/></tr><tr><td>0 &#x02013; 9&#x000a0;years</td><td>64 (71.1)</td><td>17 (53.1)</td><td>0.026</td></tr><tr><td>10 &#x02013; 12&#x000a0;years</td><td>18 (20.0)</td><td>14 (43.8)</td><td/></tr><tr><td>&#x02265;12&#x000a0;years</td><td>08 (8.9)</td><td>01 (3.1)</td><td/></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>28.8&#x02009;&#x000b1;&#x02009;5.1</td><td>30.8&#x02009;&#x000b1;&#x02009;5.5</td><td>NS</td></tr><tr><td>WC (cm)</td><td>100.1&#x02009;&#x000b1;&#x02009;12.3</td><td>104.4&#x02009;&#x000b1;&#x02009;12.5</td><td>NS</td></tr><tr><td>SBP (mmHg)</td><td>146.5&#x02009;&#x000b1;&#x02009;28.7</td><td>137.9&#x02009;&#x000b1;&#x02009;21.1</td><td>NS</td></tr><tr><td>DBP (mmHg)</td><td>81.8&#x02009;&#x000b1;&#x02009;13.7</td><td>83.2&#x02009;&#x000b1;&#x02009;13.0</td><td>NS</td></tr><tr><td>Glucose (mg/dL)</td><td>109.0 (90.0 - 137.0)</td><td>120.0 (102.5 - 174.0)</td><td>0.030&#x000a7;</td></tr><tr><td>Triglycerides (mg/dL)</td><td>153.0 (119.0 - 226.0)</td><td>211.0 (118.0 - 456.5)</td><td>NS &#x000a7;</td></tr><tr><td>Total cholesterol (mg/dL)</td><td>204.4&#x02009;&#x000b1;&#x02009;61.7</td><td>217.7&#x02009;&#x000b1;&#x02009;114.7</td><td>NS</td></tr><tr><td>HDL-cholesterol (mg/dL)</td><td>39.7&#x02009;&#x000b1;&#x02009;12.3</td><td>35.8&#x02009;&#x000b1;&#x02009;9.2</td><td>NS</td></tr><tr><td>LDL-cholesterol (mg/dL)</td><td>125.8&#x02009;&#x000b1;&#x02009;54.8</td><td>116.8&#x02009;&#x000b1;&#x02009;61.9</td><td>NS</td></tr></tbody></table><table-wrap-foot><p>n (%), Mean&#x02009;&#x000b1;&#x02009;SD, Median (25<sup>th</sup>&#x02013;75<sup>th</sup> percentile). Chi-square test, Student&#x02019;s <italic>t</italic>-test, &#x000a7; Mann&#x02013;Whitney test. NS: non-significant, AMI: acute myocardial infarction, CABG: coronary artery bypass grafting, BMI: body mass index, WC: waist circumference, SBP: systolic blood pressure, DBP: diastolic blood pressure, HDL: high density lipoprotein, LDL: low density lipoprotein</p></table-wrap-foot></table-wrap></p><p>A larger part of the study group was elderly (57.1&#x000a0;%) and there was no difference in gender distribution. Main comorbidities were diabetes and overweight and obesity, and the main events among clinical procedures were acute myocardial infarction and myocardial revascularization (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>). The drugs mostly used by the group were: statins (81.3&#x000a0;%), fibrates (33&#x000a0;%), oral hypoglycemic agents (48.4&#x000a0;%), sympatholytic agents (72.5&#x000a0;%), ACE inhibitors (53.8&#x000a0;%), diuretics (49.5&#x000a0;%), calcium channel blockers (40.7&#x000a0;%), AT1 receptor blockers (36.3&#x000a0;%), vasodilators (12.1&#x000a0;%), ASA (65.9&#x000a0;%).</p><p>Although all patients received treatment for dyslipidemia and hypertension, 60.4&#x000a0;% presented increased arterial blood pressure (systolic&#x02009;&#x02265;&#x02009;140&#x000a0;mmHg or diastolic&#x02009;&#x02265;&#x02009;80&#x000a0;mmHg). In relation to serum lipid concentrations 94.5&#x000a0;% of the patients presented some alteration on their lipid profile at the beginning of the study, being 52.7&#x000a0;% increased triglycerides (&#x02265;150&#x000a0;mg/dL), 60.4&#x000a0;% increased LDL-c (&#x0003e;100&#x000a0;mg/dL) and 33.3&#x000a0;% presented both parameters altered.</p><p>There was no change on the evolution of anthropometric and clinical parameters after twelve weeks of placebo and Brazil nut dietary interventions (data not shown), as no difference was present between diets, at the beginning or the ending periods. The same occurred for most of the biochemical parameters, however, a significant increase of HDL-c can be observed in both intervention groups (Diet&#x02009;+&#x02009;Placebo: 38.96&#x02009;&#x000b1;&#x02009;13.30 to 41.17&#x02009;&#x000b1;&#x02009;12.82; p&#x02009;&#x0003c;&#x02009;0.05 and Diet&#x02009;+&#x02009;Granulated Brazil nut: 38.66&#x02009;&#x000b1;&#x02009;11.91 to 40.82&#x02009;&#x000b1;&#x02009;14.73; p&#x02009;&#x0003c;&#x02009;0.05).</p><p>Basal plasma Se concentration from the study group was 87.0&#x02009;&#x000b1;&#x02009;16.8&#x000a0;&#x003bc;g/L and it was observed that 57.1&#x000a0;% (<italic>n</italic>&#x02009;=&#x02009;52) presented low plasma Se (&#x0003c;90&#x000a0;&#x003bc;g/L). Throughout intervention, Se plasma concentrations increased significantly with the *Brazil nut intake (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). It has been observed an overall increase in Plasma Se by 119&#x000a0;%. However, it was possible to verify the carry over effect after the washout period on placebo diet Se concentrations; this occurred because part 112of the study group who received Granulated Brazil nut supplementation on the first steps did not return to the same basal values, making plasma Se initial value to be elevated in relation to Granulated Brazil nut supplementation initial value.<fig id="Fig2"><label>Fig. 2</label><caption><p>Plasma Se levels during intervention with Brazil nut, placebo and washout period. Data are expressed as the mean&#x02009;&#x000b1;&#x02009;SD. Student&#x02019;s <italic>t</italic>-test between placebo and Granulated Brazil nut groups. * <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05</p></caption><graphic xlink:href="12937_2015_43_Fig2_HTML" id="d30e1145"/></fig></p><p>Significant increase of GPx3 activity and oxidized-LDL reduction with Granulated Brazil nut intake was observed (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). At the end of 12&#x000a0;weeks plasma total antioxidant capacity was lower on the placebo diet than on the Brazil nut diet (<italic>p</italic>&#x02009;=&#x02009;0.024).<table-wrap id="Tab2"><label>Table 2</label><caption><p>The effect of partially defatted Granulated Brazil nut on antioxidant status and oxidative stress markers in hypertensive and dyslipidemic patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="2">Diet&#x02009;+&#x02009;placebo</th><th colspan="2">Diet&#x02009;+&#x02009;Granulated Brazil nut</th></tr></thead><tbody><tr><td/><td>Before</td><td>12&#x000a0;weeks</td><td>Before</td><td>12&#x000a0;weeks</td></tr><tr><td>GPx3 (nmol/min/mL)</td><td>107.53&#x02009;&#x000b1;&#x02009;27.79</td><td>115.06&#x02009;&#x000b1;&#x02009;38.09 <sup>a</sup></td><td>112.66&#x02009;&#x000b1;&#x02009;40.09 <sup>b</sup></td><td>128.32&#x02009;&#x000b1;&#x02009;38.31 <sup>b, a</sup></td></tr><tr><td>TAC (%)</td><td>20.36&#x02009;&#x000b1;&#x02009;4.44</td><td>18.75&#x02009;&#x000b1;&#x02009;5.64 <sup>c</sup></td><td>20.13&#x02009;&#x000b1;&#x02009;4.68</td><td>20.41&#x02009;&#x000b1;&#x02009;4.80 <sup>c</sup></td></tr><tr><td>8-epi PGF<sub>2&#x003b1;</sub> (pg/mL)</td><td>14.57&#x02009;&#x000b1;&#x02009;7.84 <sup>d</sup></td><td>16.37&#x02009;&#x000b1;&#x02009;9.81<sup>d</sup></td><td>15.83&#x02009;&#x000b1;&#x02009;9.50</td><td>15.65&#x02009;&#x000b1;&#x02009;8.08</td></tr><tr><td>Oxidized LDL (U/L)</td><td>64.43&#x02009;&#x000b1;&#x02009;20.97</td><td>63.76&#x02009;&#x000b1;&#x02009;23.03</td><td>66.31&#x02009;&#x000b1;&#x02009;23.59 <sup>e</sup></td><td>60.68&#x02009;&#x000b1;&#x02009;20.88 <sup>e</sup></td></tr><tr><td>Ox LDL /LDL-c</td><td>0.56&#x02009;&#x000b1;&#x02009;0.18</td><td>0.57&#x02009;&#x000b1;&#x02009;0.19</td><td>0.57&#x02009;&#x000b1;&#x02009;0.18</td><td>0.53&#x02009;&#x000b1;&#x02009;0.15</td></tr></tbody></table><table-wrap-foot><p>Mean&#x02009;&#x000b1;&#x02009;SD. <sup>a, b, c, d, e</sup> p&#x02009;&#x0003c;&#x02009;0.05. Means followed by the same alphabetic letter are statistic different. Paired Student&#x02019;s <italic>t</italic>-test (<sup>b, d, e</sup>) and Student&#x02019;s <italic>t</italic>-test (<sup>a, c</sup>). GPx3: plasma glutathione peroxidase; TAC: total antioxidant capacity of plasma; 8-epi PGF<sub>2&#x003b1;</sub>: 8-epi prostaglandine F<sub>2&#x003b1;</sub>; LDL: low density lipoprotein; Ox LDL: oxidized low density lipoprotein</p></table-wrap-foot></table-wrap></p><p>The oxidative stress markers variation percentage and antioxidant capacity according to dietary intervention at the end of the study is presented in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>. It was observed increase in GPx3 activity by 24.8&#x000a0;% in Granulated Brazil Nut and it was statistical different from placebo (<italic>p</italic>&#x02009;=&#x02009;0.034), an oxidized-LDL reduction by 3.2&#x000a0;% after Granulated Brazil Nut intervention but it was no statistical different from placebo. There were no statistical difference between Granulated Brazil Nut and placebo for plasma total antioxidant capacity and 8-epi PGF2&#x003b1; (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><p>Changes at 12&#x000a0;weeks in the markers of antioxidant status and oxidative stress. # p&#x02009;&#x0003c;&#x02009;0.05. Student&#x02019;s <italic>t</italic>-test (<bold>a</bold>, <bold>b</bold>, <bold>c</bold>, <bold>d</bold>). GPx3: plasma glutathione peroxidase; TAC: total antioxidant capacity of plasma; 8-epi PGF<sub>2&#x003b1;</sub>: 8-epi prostaglandin F<sub>2&#x003b1;</sub>; LDL: low density lipoprotein</p></caption><graphic xlink:href="12937_2015_43_Fig3_HTML" id="d30e1358"/></fig></p><p>A significant inverse association between oxidized-LDL and GPx3 activity after Granulated Brazil nut intake is shown in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref> with a simple linear regression model (B&#x02009;&#x02212;&#x02009;0.434, IC 95&#x000a0;%&#x02009;&#x02212;&#x02009;0.829;&#x02212;0039, &#x003b2;&#x02009;&#x02212;&#x02009;0.232, <italic>p</italic>&#x02009;=&#x02009;0.032) and it remained significant after adjustment for age, BMI, gender, diabetes and smoking status (B&#x02009;&#x02212;&#x02009;0.556, IC 95&#x000a0;%&#x02009;&#x02212;&#x02009;0.963;&#x02212;0148, &#x003b2;&#x02009;&#x02212;&#x02009;0.298, <italic>p</italic>&#x02009;=&#x02009;0.008). However no statistical significance was observed between 8-epi PGF2&#x003b1; and GPx3 activity with the simple linear regression model (B&#x02009;&#x02212;&#x02009;0.991, IC 95&#x000a0;%&#x02009;&#x02212;&#x02009;1.991;&#x02212;0009, &#x003b2;&#x02009;&#x02212;&#x02009;0.209, <italic>p</italic>&#x02009;=&#x02009;0.052) as shown in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>. Nevertheless, a significant inverse association between 8-epi PGF2&#x003b1; and GPx3 activity was achieved after adjustment for age, BMI, gender and diabetes (B&#x02009;&#x02212;&#x02009;1.082, IC 95&#x000a0;%&#x02009;&#x02212;&#x02009;2.081;&#x02212;0.084, &#x003b2;&#x02009;&#x02212;&#x02009;0.234, <italic>p</italic>&#x02009;=&#x02009;0.034).<fig id="Fig4"><label>Fig. 4</label><caption><p>Association between GPx3 activity and biomarkers of oxidative stress. Simple linear regression. <bold>a</bold>. Granulated Brazil nut (<italic>p</italic>&#x02009;=&#x02009;0.032) and Placebo (<italic>p</italic>&#x02009;=&#x02009;0.371); <bold>b</bold>. Granulated Brazil nut (<italic>p</italic>&#x02009;=&#x02009;0.052) e Placebo (<italic>p</italic>&#x02009;=&#x02009;0.836)</p></caption><graphic xlink:href="12937_2015_43_Fig4_HTML" id="d30e1407"/></fig></p></sec><sec id="Sec11"><title>Discussion</title><p>The present study showed that the partially defatted Granulated Brazil nut (13&#x000a0;g/day, providing 227.5&#x000a0;&#x003bc;g) in a serum lipid and blood pressure reduction diet for dyslipdemic and hypertensive patients, increased antioxidant status and reduced oxidative stress. The relationship of these effects were inversely proportional.</p><p>The Brazil nut also has an important amount of antioxidants compounds, such as almonds, hazelnuts, macadamia nuts, pine cones, and cashew nuts [<xref ref-type="bibr" rid="CR36">36</xref>]. The Brazil nut is the food with the highest amount of Se in its composition [<xref ref-type="bibr" rid="CR1">1</xref>]. Se is a mineral which is involved with the protection against oxidative stress via selenoproteins as glutathione peroxidase, participanting of this enzyme active site [<xref ref-type="bibr" rid="CR29">29</xref>]. Besides, Brazil nut is high in &#x003b2;-tocopherol (88.3&#x000a0;% of total tocopherols), a potent antioxidant [<xref ref-type="bibr" rid="CR37">37</xref>].</p><p>Thomson <italic>et al.</italic> demonstrated that the Brazil nut intake significantly improved GPx activity on individuals with low plasma Se compared to selenomethionine or placebo [<xref ref-type="bibr" rid="CR4">4</xref>]. SELGEN study measured the Se status of healthy volunteers before and after supplementation with 100&#x000a0;&#x003bc;g Se/day for six weeks followed by a washout period of six weeks, and the authors showed a rapid and significant decrease in plasma Se status to baseline levels after two weeks and continued to fall at fourth week after which time it was similar to baseline concentration [<xref ref-type="bibr" rid="CR20">20</xref>]. However in the present study there was a carryover effect, maybe because of the selenium dose which was two-fold SELGEN study dose, and the main pools of Se in human body are selenoproteins and selenomethionine [<xref ref-type="bibr" rid="CR38">38</xref>].</p><p>Many enzymatic processes can generate ROS on the human body, and there are evidences that connect these processes to cardiovascular diseases pathophysiology [<xref ref-type="bibr" rid="CR12">12</xref>]. The lipid peroxidation process is initiated by a ROS reaction with a unsaturated fatty acid and propagated by peroxyl radicals [<xref ref-type="bibr" rid="CR39">39</xref>]. Glutathione peroxidase biochemical function is reducing lipid hydroperoxides to their correspondent alcohols and decreasing free hydrogen peroxide to water [<xref ref-type="bibr" rid="CR40">40</xref>]. GPx1 enzyme (eritrocity) activity was reduced in CAD patients and low activity of this enzyme was a predictor to cardiovascular event in five-year&#x02019;s time [<xref ref-type="bibr" rid="CR41">41</xref>]. Similar to the present study, other studies also observed GPx activity increase after Brazil nut supplementation in obese women [<xref ref-type="bibr" rid="CR42">42</xref>] and CKD patients in hemodialysis [<xref ref-type="bibr" rid="CR43">43</xref>]. In addition, it has been observed that the overall increase in Plasma Se and plasma GPx activity was higher than Thomson <italic>et al.</italic> showed with a low plasma Se subjects [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p>The oxidation of LDL was increased in the familial hypercholestolemia, hypertriglyceridemia, diabetes and coronary artery disease [<xref ref-type="bibr" rid="CR44">44</xref>]. Clinical trials evaluating different types and quantities of nuts indicated improvement of oxidative stress after nuts&#x02019; intake [<xref ref-type="bibr" rid="CR45">45</xref>]. The reduction of average 15&#x000a0;% on oxidized-LDL in hyperlipidemic men and women was observed after almonds intake (37 or 75&#x000a0;g/day) for a month, compared to the control diet [<xref ref-type="bibr" rid="CR46">46</xref>]. The present study showed a modest significant reduction in oxidized-LDL after Granulated Brazil nut intake, and it can be attributed to the complex health status of these patients related to duration of disease, previous cardiovascular event and poor blood pressure control and serum lipids control, which may have influenced the findings. However, the observation of such reduction has been inversely associated with GPx3 activity increase, demonstrating a beneficial relationship of Brazil nut antioxidants properties as part of hypertensive and dyslipidemic patients&#x02019; nutrition intervention.</p><p>High concentrations of F2-isoprostanes are associated with the coronary artery disease extension and severity [<xref ref-type="bibr" rid="CR47">47</xref>]. In other study, the Brazil nut intake (15 a 25&#x000a0;g/day) for four months did not alter urinary 8-epi PGF2&#x003b1; in female obese teenagers [<xref ref-type="bibr" rid="CR48">48</xref>]. In the same way, 13&#x000a0;g/day Granulated Brazil nut consumption in the present study did not alter 8-epi PGF2&#x003b1; plasma concentration after twelve week, but an inverse correlation of this biomarker was observed with GPx3 activity, however it was not significant.</p><p>The present study has limitations that may have influenced the findings. Such limitations include the cohort of participants who did not complete the study whose age was significantly less than those who did complete the study, the relative short intervention period, the heterogeneity of the participants, and the carry-over effect in relation to plasma selenium concentrations. However, the crossover design allows the patient to be their own control. Finally, partially defatted Granulated Brazil nut are easy to include in one&#x02019;s diet and use in daily recipes.</p><p>The present study contributes to the rising evidence which demonstrates the beneficial effects of nuts over CVD risk factors. Our data showed that Granulated Brazil nut can be recommended as part of a healthy diet for the heart, since it has a potential benefit to increase plasma selenium, increase enzymatic antioxidant activity of GPx3 and to reduction oxidation in LDL in hypertensive and dyslipidemic patients.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ACE</term><def><p>Angiotensin-converting enzyme</p></def></def-item><def-item><term>AMI</term><def><p>Acute myocardial infarction</p></def></def-item><def-item><term>ASA</term><def><p>Acetylsalicylic acid</p></def></def-item><def-item><term>BMI</term><def><p>Body mass index</p></def></def-item><def-item><term>CABG</term><def><p>Coronary artery bypass grafting</p></def></def-item><def-item><term>CHD</term><def><p>Coronary heart disease</p></def></def-item><def-item><term>DBP</term><def><p>Diastolic blood pressure</p></def></def-item><def-item><term>HDL</term><def><p>High-density lipoprotein</p></def></def-item><def-item><term>LDL</term><def><p>Low-density lipoprotein</p></def></def-item><def-item><term>SBP</term><def><p>Systolic blood pressure</p></def></def-item><def-item><term>Se</term><def><p>Selenium</p></def></def-item><def-item><term>WC</term><def><p>Waist circumference</p></def></def-item><def-item><term>GPx3</term><def><p>Plasma glutathione peroxidase</p></def></def-item><def-item><term>TAC</term><def><p>Total antioxidant capacity of plasma</p></def></def-item><def-item><term>8-epi PGF<sub>2&#x003b1;</sub></term><def><p>8-epi prostaglandine F<sub>2&#x003b1;</sub></p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Competing interests</bold></p><p>The authors declare that they have no competing interests.</p></fn><fn><p><bold>Authors&#x02019; contributions</bold></p><p>The authors&#x02019; contributions were as follows: GVBH &#x02013; designed the study, followed the subjects, carried out data collection, performed the all the assays and drafted the manuscript. ASBM, GR, GMMO - designed the study and participated in drafting the manuscript. ARPM and AJT &#x02013; contributed to the assessment antioxidant biomarkers and participated in drafting the manuscript. TDSP, RAG &#x02013; contributed to the analysis of plasma selenium and Granulated Brazil nut selenium, respectively. RRL &#x02013; contributed to the statistical analyses. All authors read and approved the final manuscript.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors would like to thank all of the study subjects for their participation. Also thank FAPERJ (Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa, Rio de Janeiro, Brazil), National Institute of Cardiology (Rio de Janeiro, Brazil) and FUNDACOR (Funda&#x000e7;&#x000e3;o Pr&#x000f3;-Cora&#x000e7;&#x000e3;o) for the financial support.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freitas</surname><given-names>SCS</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>EB</given-names></name><name><surname>Antoniassi</surname><given-names>R</given-names></name><name><surname>Felberg</surname><given-names>I</given-names></name><name><surname>Oliveira</surname><given-names>SPD</given-names></name></person-group><article-title>Meta-analysis of selenium content in Brazil nuts</article-title><source>Braz J Food Technol</source><year>2008</year><volume>11</volume><fpage>54</fpage><lpage>62</lpage></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schomburg</surname><given-names>L</given-names></name><name><surname>K&#x000f6;hrle</surname><given-names>J</given-names></name></person-group><article-title>On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health</article-title><source>Mol Nutr Food Res</source><year>2008</year><volume>52</volume><fpage>1235</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1002/mnfr.200700465</pub-id><pub-id pub-id-type="pmid">18686295</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayman</surname><given-names>MP</given-names></name></person-group><article-title>The importance of selenium to human health</article-title><source>Lancet</source><year>2000</year><volume>356</volume><fpage>233</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(00)02490-9</pub-id><pub-id pub-id-type="pmid">10963212</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomson</surname><given-names>CD</given-names></name><name><surname>Chisholm</surname><given-names>A</given-names></name><name><surname>McLachlan</surname><given-names>SK</given-names></name><name><surname>Campbell</surname><given-names>JM</given-names></name></person-group><article-title>Brazil nuts: an effective way to improve selenium status</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>87</volume><fpage>379</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">18258628</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oktyabrsky</surname><given-names>O</given-names></name><name><surname>Smirnova</surname><given-names>G</given-names></name></person-group><article-title>Redox regulation of cellular functions</article-title><source>Biochemistry (Moscow)</source><year>2007</year><volume>72</volume><fpage>132</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1134/S0006297907020022</pub-id><pub-id pub-id-type="pmid">17367290</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasconcelos</surname><given-names>SML</given-names></name><name><surname>Goulart</surname><given-names>MOF</given-names></name><name><surname>Moura</surname><given-names>JBDF</given-names></name><name><surname>Manfredini</surname><given-names>V</given-names></name><name><surname>Benfato</surname><given-names>MDS</given-names></name><name><surname>Kubota</surname><given-names>LT</given-names></name></person-group><article-title>Esp&#x000e9;cies reativas de oxig&#x000ea;nio e de nitrog&#x000ea;nio, antioxidantes e marcadores de dano oxidativo em sangue humano: principais m&#x000e9;todos anal&#x000ed;ticos para sua determina&#x000e7;&#x000e3;o</article-title><source>Qu&#x000ed;m Nova</source><year>2007</year><volume>30</volume><fpage>1323</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1590/S0100-40422007000500046</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Landmesser</surname><given-names>U</given-names></name><name><surname>Drexler</surname><given-names>H</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Bourassa</surname><given-names>M</given-names></name><name><surname>Tardif</surname><given-names>J-C</given-names></name></person-group><article-title>General Concepts about Oxidative Stress</article-title><source>Antioxidants and Cardiovascular Disease</source><year>2006</year><publisher-loc>Springer US</publisher-loc><publisher-name>Developments in Cardiovascular Medicine</publisher-name><fpage>1</fpage><lpage>15</lpage></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brash</surname><given-names>AR</given-names></name></person-group><article-title>Lipoxygenases: occurrence, functions, catalysis, and acquisition of substrate</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>23679</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.34.23679</pub-id><pub-id pub-id-type="pmid">10446122</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Funk</surname><given-names>CD</given-names></name></person-group><article-title>Lipoxygenase pathways in atherogenesis</article-title><source>Trends Cardiovasc Med</source><year>2004</year><volume>14</volume><fpage>191</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.tcm.2004.04.003</pub-id><pub-id pub-id-type="pmid">15261891</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hulthe</surname><given-names>J</given-names></name><name><surname>Fagerberg</surname><given-names>B</given-names></name></person-group><article-title>Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study)</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2002</year><volume>22</volume><fpage>1162</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.0000021150.63480.CD</pub-id><pub-id pub-id-type="pmid">12117732</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meisinger</surname><given-names>C</given-names></name><name><surname>Baumert</surname><given-names>J</given-names></name><name><surname>Khuseyinova</surname><given-names>N</given-names></name><name><surname>Loewel</surname><given-names>H</given-names></name><name><surname>Koenig</surname><given-names>W</given-names></name></person-group><article-title>Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population</article-title><source>Circulation</source><year>2005</year><volume>112</volume><fpage>651</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.104.529297</pub-id><pub-id pub-id-type="pmid">16043640</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugamura</surname><given-names>K</given-names></name><name><surname>Keaney</surname><given-names>JJF</given-names></name></person-group><article-title>Reactive oxygen species in cardiovascular disease</article-title><source>Free Radic Biol Med</source><year>2011</year><volume>51</volume><fpage>978</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.05.004</pub-id><pub-id pub-id-type="pmid">21627987</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morrow</surname><given-names>JD</given-names></name></person-group><article-title>Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2005</year><volume>25</volume><fpage>279</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.0000152605.64964.c0</pub-id><pub-id pub-id-type="pmid">15591226</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chobanian</surname><given-names>AV</given-names></name><name><surname>Bakris</surname><given-names>GL</given-names></name><name><surname>Black</surname><given-names>HR</given-names></name><name><surname>Cushman</surname><given-names>WC</given-names></name><name><surname>Green</surname><given-names>LA</given-names></name><name><surname>Izzo</surname><given-names>JL</given-names><suffix>Jr</suffix></name><etal/></person-group><article-title>Seventh report of the joint National Committee on Prevention, detection, evaluation, and treatment of high blood pressure</article-title><source>Hypertension</source><year>2003</year><volume>42</volume><fpage>1206</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000107251.49515.c2</pub-id><pub-id pub-id-type="pmid">14656957</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Red&#x000f3;n</surname><given-names>J</given-names></name><name><surname>Oliva</surname><given-names>MR</given-names></name><name><surname>Tormos</surname><given-names>C</given-names></name><name><surname>Giner</surname><given-names>V</given-names></name><name><surname>Chaves</surname><given-names>J</given-names></name><name><surname>Iradi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Antioxidant activities and oxidative stress byproducts in human hypertension</article-title><source>Hypertension</source><year>2003</year><volume>41</volume><fpage>1096</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000068370.21009.38</pub-id><pub-id pub-id-type="pmid">12707286</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poss</surname><given-names>J</given-names></name><name><surname>Custodis</surname><given-names>F</given-names></name><name><surname>Werner</surname><given-names>C</given-names></name><name><surname>Weingartner</surname><given-names>O</given-names></name><name><surname>Bohm</surname><given-names>M</given-names></name><name><surname>Laufs</surname><given-names>U</given-names></name></person-group><article-title>Cardiovascular disease and dyslipidemia: beyond LDL</article-title><source>Curr Pharm Des</source><year>2011</year><volume>17</volume><fpage>861</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.2174/138161211795428858</pub-id><pub-id pub-id-type="pmid">21418031</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Cheserek</surname><given-names>MJ</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Le</surname><given-names>G</given-names></name></person-group><article-title>[Comparison of serum lipid and protein oxidation products levels in patients with different types of dyslipidemia]</article-title><source>Wei Sheng Yan Jiu J Hyg Res</source><year>2014</year><volume>43</volume><fpage>529</fpage><lpage>34</lpage></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Hipertens&#x000e3;o, Sociedade Brasileira de Nefrologia</collab></person-group><article-title>VI Diretrizes Brasileiras de Hipertens&#x000e3;o</article-title><source>Arq Bras Cardiol</source><year>2010</year><volume>95</volume><issue>1 supl.1</issue><fpage>1</fpage><lpage>51</lpage></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sposito</surname><given-names>AC</given-names></name><name><surname>Caramelli</surname><given-names>B</given-names></name><name><surname>Fonseca</surname><given-names>FAH</given-names></name><name><surname>Bertolami</surname><given-names>MC</given-names></name><name><surname>Afiune Neto</surname><given-names>A</given-names></name><name><surname>Souza</surname><given-names>AD</given-names></name><etal/></person-group><article-title>IV Diretriz Brasileira sobre Dislipidemias e Preven&#x000e7;&#x000e3;o da Aterosclerose: Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia</article-title><source>Arq Bras Cardiol</source><year>2007</year><volume>88</volume><fpage>2</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1590/S0066-782X2007000700002</pub-id><pub-id pub-id-type="pmid">17515982</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000e9;plan</surname><given-names>C</given-names></name><name><surname>Crosley</surname><given-names>LK</given-names></name><name><surname>Nicol</surname><given-names>F</given-names></name><name><surname>Beckett</surname><given-names>GJ</given-names></name><name><surname>Howie</surname><given-names>AF</given-names></name><name><surname>Hill</surname><given-names>KE</given-names></name><etal/></person-group><article-title>Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study)</article-title><source>FASEB J</source><year>2007</year><volume>21</volume><fpage>3063</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1096/fj.07-8166com</pub-id><pub-id pub-id-type="pmid">17536041</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Agricultural Research Service</collab></person-group><source>USDA National Nutrient Database for Standard Reference, Release 26</source><year>2013</year></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Institute of Medicine, Food and Nutrition Board</collab></person-group><source>Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients)</source><year>2005</year><publisher-loc>Washington, D.C.</publisher-loc><publisher-name>The National Academic Press</publisher-name></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benincasa</surname><given-names>C</given-names></name><name><surname>Lewis</surname><given-names>J</given-names></name><name><surname>Perri</surname><given-names>E</given-names></name><name><surname>Sindona</surname><given-names>G</given-names></name><name><surname>Tagarelli</surname><given-names>A</given-names></name></person-group><article-title>Determination of trace element in Italian virgin olive oils and their characterization according to geographical origin by statistical analysis</article-title><source>Anal Chim Acta</source><year>2007</year><volume>585</volume><fpage>366</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.aca.2006.12.040</pub-id><pub-id pub-id-type="pmid">17386687</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>VB</given-names></name><name><surname>Siqueira</surname><given-names>KS</given-names></name><name><surname>Sichieri</surname><given-names>R</given-names></name></person-group><article-title>Atividade f&#x000ed;sica em uma amostra probabil&#x000ed;stica da popula&#x000e7;&#x000e3;o do Munic&#x000ed;pio do Rio de Janeiro</article-title><source>Cad Saude Publica</source><year>2001</year><volume>17</volume><fpage>969</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1590/S0102-311X2001000400031</pub-id><pub-id pub-id-type="pmid">11514878</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Physical Activity Guidelines Advisory Committee</collab></person-group><source>Physical Activity Guidelines Advisory Committee Report, 2008</source><year>2008</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>U.S. Department of Health and Human Services</publisher-name></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>WHO</collab></person-group><source>Obesity: preventing and managing the global epidemic : report of a WHO consultation</source><year>1998</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedewald</surname><given-names>WT</given-names></name><name><surname>Levy</surname><given-names>RI</given-names></name><name><surname>Fredrickson</surname><given-names>DS</given-names></name></person-group><article-title>Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge</article-title><source>Clin Chem</source><year>1972</year><volume>18</volume><fpage>499</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">4337382</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labat</surname><given-names>L</given-names></name><name><surname>Dehon</surname><given-names>B</given-names></name><name><surname>Lhermitte</surname><given-names>M</given-names></name></person-group><article-title>Rapid and simple determination of selenium in blood serum by inductively coupled plasma&#x02013;mass spectrometry (ICP&#x02013;MS)</article-title><source>Anal Bioanal Chem</source><year>2003</year><volume>376</volume><fpage>270</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">12677338</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayman</surname><given-names>MP</given-names></name></person-group><article-title>Selenium and human health</article-title><source>Lancet</source><year>2012</year><volume>379</volume><fpage>1256</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(11)61452-9</pub-id><pub-id pub-id-type="pmid">22381456</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paglia</surname><given-names>DE</given-names></name><name><surname>Valentine</surname><given-names>WN</given-names></name></person-group><article-title>Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase</article-title><source>J Lab Clin Med</source><year>1967</year><volume>70</volume><fpage>158</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">6066618</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janaszewska</surname><given-names>A</given-names></name><name><surname>Bartosz</surname><given-names>G</given-names></name></person-group><article-title>Assay of total antioxidant capacity: comparison of four methods as applied to human blood plasma</article-title><source>Scand J Clin Lab Invest</source><year>2002</year><volume>62</volume><fpage>231</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1080/003655102317475498</pub-id><pub-id pub-id-type="pmid">12088342</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Maclouf</surname><given-names>J</given-names></name><name><surname>Grassi</surname><given-names>J</given-names></name><name><surname>Pradelles</surname><given-names>P</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Walden</surname><given-names>T</given-names><suffix>Jr</suffix></name><name><surname>Hughes</surname><given-names>H</given-names></name></person-group><article-title>Development of Enzyme-Immunoassay Techniques for Measurement of Eicosanoids</article-title><source>Prostaglandin and Lipid Metabolism in Radiation Injury</source><year>1987</year><publisher-loc>US</publisher-loc><publisher-name>Springer</publisher-name><fpage>355</fpage><lpage>364</lpage></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pradelles</surname><given-names>P</given-names></name><name><surname>Grassi</surname><given-names>J</given-names></name><name><surname>Maclouf</surname><given-names>J</given-names></name></person-group><article-title>Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay</article-title><source>Anal Chem</source><year>1985</year><volume>57</volume><fpage>1170</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1021/ac00284a003</pub-id><pub-id pub-id-type="pmid">3898913</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holvoet</surname><given-names>P</given-names></name><name><surname>Mertens</surname><given-names>A</given-names></name><name><surname>Verhamme</surname><given-names>P</given-names></name><name><surname>Bogaerts</surname><given-names>K</given-names></name><name><surname>Beyens</surname><given-names>G</given-names></name><name><surname>Verhaeghe</surname><given-names>R</given-names></name><etal/></person-group><article-title>Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2001</year><volume>21</volume><fpage>844</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1161/01.ATV.21.5.844</pub-id><pub-id pub-id-type="pmid">11348884</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holvoet</surname><given-names>P</given-names></name><name><surname>Vanhaecke</surname><given-names>J</given-names></name><name><surname>Janssens</surname><given-names>S</given-names></name><name><surname>Van de Werf</surname><given-names>F</given-names></name><name><surname>Collen</surname><given-names>D</given-names></name></person-group><article-title>Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease</article-title><source>Circulation</source><year>1998</year><volume>98</volume><fpage>1487</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.98.15.1487</pub-id><pub-id pub-id-type="pmid">9769301</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blomhoff</surname><given-names>R</given-names></name><name><surname>Carlsen</surname><given-names>MH</given-names></name><name><surname>Andersen</surname><given-names>LF</given-names></name><name><surname>Jacobs</surname><given-names>DR</given-names></name></person-group><article-title>Health benefits of nuts: potential role of antioxidants</article-title><source>Br J Nutr</source><year>2006</year><volume>96</volume><fpage>S52</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1017/BJN20061864</pub-id><pub-id pub-id-type="pmid">17125534</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chunhieng</surname><given-names>T</given-names></name><name><surname>Hafidi</surname><given-names>A</given-names></name><name><surname>Pioch</surname><given-names>D</given-names></name><name><surname>Brochier</surname><given-names>J</given-names></name><name><surname>Didier</surname><given-names>M</given-names></name></person-group><article-title>Detailed study of Brazil nut (Bertholletiaexcelsa) oil micro-compounds: phospholipids, tocopherols and sterols</article-title><source>J Braz Chem Soc</source><year>2008</year><volume>19</volume><fpage>1374</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1590/S0103-50532008000700021</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>Institute of Medicine, Food and Nutrition Board</collab></person-group><article-title>Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids</article-title><source>Book Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids</source><year>2000</year><publisher-loc>Washington, D.C</publisher-loc><publisher-name>The National Academies Press</publisher-name><fpage>531</fpage></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niki</surname><given-names>E</given-names></name><name><surname>Yoshida</surname><given-names>Y</given-names></name><name><surname>Saito</surname><given-names>Y</given-names></name><name><surname>Noguchi</surname><given-names>N</given-names></name></person-group><article-title>Lipid peroxidation: mechanisms, inhibition, and biological effects</article-title><source>Biochem Biophys Res Commun</source><year>2005</year><volume>338</volume><fpage>668</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2005.08.072</pub-id><pub-id pub-id-type="pmid">16126168</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajendran</surname><given-names>P</given-names></name><name><surname>Nandakumar</surname><given-names>N</given-names></name><name><surname>Rengarajan</surname><given-names>T</given-names></name><name><surname>Palaniswami</surname><given-names>R</given-names></name><name><surname>Gnanadhas</surname><given-names>EN</given-names></name><name><surname>Lakshminarasaiah</surname><given-names>U</given-names></name><etal/></person-group><article-title>Antioxidants and human diseases</article-title><source>Clin Chim Acta</source><year>2014</year><volume>436</volume><fpage>332</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.cca.2014.06.004</pub-id><pub-id pub-id-type="pmid">24933428</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blankenberg</surname><given-names>S</given-names></name><name><surname>Rupprecht</surname><given-names>HJ</given-names></name><name><surname>Bickel</surname><given-names>C</given-names></name><name><surname>Torzewski</surname><given-names>M</given-names></name><name><surname>Hafner</surname><given-names>G</given-names></name><name><surname>Tiret</surname><given-names>L</given-names></name><etal/></person-group><article-title>Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease</article-title><source>N Engl J Med</source><year>2003</year><volume>349</volume><fpage>1605</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa030535</pub-id><pub-id pub-id-type="pmid">14573732</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cominetti</surname><given-names>C</given-names></name><name><surname>de Bortoli</surname><given-names>MC</given-names></name><name><surname>Garrido</surname><given-names>AB</given-names><suffix>Jr</suffix></name><name><surname>Cozzolino</surname><given-names>SMF</given-names></name></person-group><article-title>Brazilian nut consumption improves selenium status and glutathione peroxidase activity and reduces atherogenic risk in obese women</article-title><source>Nutr Res</source><year>2012</year><volume>32</volume><fpage>403</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.nutres.2012.05.005</pub-id><pub-id pub-id-type="pmid">22749175</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockler-Pinto</surname><given-names>MB</given-names></name><name><surname>Mafra</surname><given-names>D</given-names></name><name><surname>Farage</surname><given-names>NE</given-names></name><name><surname>Boaventura</surname><given-names>GT</given-names></name><name><surname>Cozzolino</surname><given-names>SM</given-names></name></person-group><article-title>Effect of Brazil nut supplementation on the blood levels of selenium and glutathione peroxidase in hemodialysis patients</article-title><source>Nutrition</source><year>2010</year><volume>26</volume><fpage>1065</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2009.08.006</pub-id><pub-id pub-id-type="pmid">20018488</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mello</surname><given-names>AP</given-names></name><name><surname>da Silva</surname><given-names>IT</given-names></name><name><surname>Abdalla</surname><given-names>DS</given-names></name><name><surname>Damasceno</surname><given-names>NR</given-names></name></person-group><article-title>Electronegative low-density lipoprotein: origin and impact on health and disease</article-title><source>Atherosclerosis</source><year>2011</year><volume>215</volume><fpage>257</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2010.12.028</pub-id><pub-id pub-id-type="pmid">21292266</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kris-Etherton</surname><given-names>PM</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name><name><surname>Ros</surname><given-names>E</given-names></name><name><surname>Sabate</surname><given-names>J</given-names></name></person-group><article-title>The role of tree nuts and peanuts in the prevention of coronary heart disease: multiple potential mechanisms</article-title><source>J Nutr</source><year>2008</year><volume>138</volume><fpage>1746s</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">18716180</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>DJ</given-names></name><name><surname>Kendall</surname><given-names>CW</given-names></name><name><surname>Marchie</surname><given-names>A</given-names></name><name><surname>Parker</surname><given-names>TL</given-names></name><name><surname>Connelly</surname><given-names>PW</given-names></name><name><surname>Qian</surname><given-names>W</given-names></name><etal/></person-group><article-title>Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial</article-title><source>Circulation</source><year>2002</year><volume>106</volume><fpage>1327</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1161/01.CIR.0000028421.91733.20</pub-id><pub-id pub-id-type="pmid">12221048</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vassalle</surname><given-names>C</given-names></name><name><surname>Botto</surname><given-names>N</given-names></name><name><surname>Andreassi</surname><given-names>MG</given-names></name><name><surname>Berti</surname><given-names>S</given-names></name><name><surname>Biagini</surname><given-names>A</given-names></name></person-group><article-title>Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress <italic>in vivo</italic>, in patients with coronary artery disease</article-title><source>Coron Artery Dis</source><year>2003</year><volume>14</volume><fpage>213</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12702924</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maranhao</surname><given-names>P</given-names></name><name><surname>Kraemer-Aguiar</surname><given-names>L</given-names></name><name><surname>de Oliveira</surname><given-names>C</given-names></name><name><surname>Kuschnir</surname><given-names>M</given-names></name><name><surname>Vieira</surname><given-names>Y</given-names></name><name><surname>Souza</surname><given-names>M</given-names></name><etal/></person-group><article-title>Brazil nuts intake improves lipid profile, oxidative stress and microvascular function in obese adolescents: a randomized controlled trial</article-title><source>Nutr Metab</source><year>2011</year><volume>8</volume><fpage>32</fpage><pub-id pub-id-type="doi">10.1186/1743-7075-8-32</pub-id></element-citation></ref></ref-list></back></article>